Abstract

The VOICE trial was a multisite study of HIV-1 prevention among women in sub-Saharan Africa that compared tenofovir (TFV), tenofovir/emtricitabine, and

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call